HFS
NBIX icon

Hughes Financial Services’s Neurocrine Biosciences NBIX Stock Holding History

Hughes Financial Services’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.07K Buy
36
+27
+300% +$4.01K ﹤0.01% 464
2026
Q1 		$1.19K Buy
9
+4
+80% +$531 ﹤0.01% 721
2025
Q4 		$709 Hold
5
– – ﹤0.01% 822
2025
Q3 		$750 Hold
5
– – ﹤0.01% 797
2025
Q2 		$642 Buy
5
+1
+25% +$115 ﹤0.01% 840
2025
Q1 		$428 Buy
+4
New +$507 ﹤0.01% 997

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Hughes Financial Services's NBIX Position: Q2 2026 in Review

Hughes Financial Services increased its Neurocrine Biosciences (NBIX) stake by 300% in Q2 2026, buying an estimated $4.01K and bringing the position to 36 shares worth $6.07K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Hughes Financial Services first reported a position in NBIX in Q1 2025 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Hughes Financial Services held 36 shares of Neurocrine Biosciences worth $6.07K as of Q2 2026.
  • Hughes Financial Services bought 27 Neurocrine Biosciences shares in Q2 2026, an estimated $4.01K.
  • Neurocrine Biosciences made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #464 holding.
  • Hughes Financial Services first reported a position in Neurocrine Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.